These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice. Kroy DC; Schumacher F; Ramadori P; Hatting M; Bergheim I; Gassler N; Boekschoten MV; Müller M; Streetz KL; Trautwein C J Hepatol; 2014 Oct; 61(4):883-90. PubMed ID: 24845607 [TBL] [Abstract][Full Text] [Related]
7. Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress. Liu J; Yang P; Zuo G; He S; Tan W; Zhang X; Su C; Zhao L; Wei L; Chen Y; Ruan X; Chen Y Lipids Health Dis; 2018 Jul; 17(1):153. PubMed ID: 30016988 [TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 expression in hepatocytes attenuates non-alcoholic steatohepatitis and liver fibrosis in mice. Motiño O; Agra N; Brea Contreras R; Domínguez-Moreno M; García-Monzón C; Vargas-Castrillón J; Carnovale CE; Boscá L; Casado M; Mayoral R; Valdecantos MP; Valverde ÁM; Francés DE; Martín-Sanz P Biochim Biophys Acta; 2016 Sep; 1862(9):1710-23. PubMed ID: 27321932 [TBL] [Abstract][Full Text] [Related]
9. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease. Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951 [TBL] [Abstract][Full Text] [Related]
10. Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction. Li S; Li X; Chen F; Liu M; Ning L; Yan Y; Zhang S; Huang S; Tu C J Nutr Biochem; 2022 Feb; 100():108888. PubMed ID: 34695558 [TBL] [Abstract][Full Text] [Related]
11. Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice. Kim KH; Kim SH; Han DH; Jo YS; Lee YH; Lee MS Sci Rep; 2018 May; 8(1):6789. PubMed ID: 29717162 [TBL] [Abstract][Full Text] [Related]
12. p16 deficiency promotes nonalcoholic steatohepatitis via regulation of hepatic oxidative stress. Lv F; Wu J; Miao D; An W; Wang Y Biochem Biophys Res Commun; 2017 Apr; 486(2):264-269. PubMed ID: 28286271 [TBL] [Abstract][Full Text] [Related]
14. Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis. Wang X; Zheng Z; Caviglia JM; Corey KE; Herfel TM; Cai B; Masia R; Chung RT; Lefkowitch JH; Schwabe RF; Tabas I Cell Metab; 2016 Dec; 24(6):848-862. PubMed ID: 28068223 [TBL] [Abstract][Full Text] [Related]
15. Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent. Gan LT; Van Rooyen DM; Koina ME; McCuskey RS; Teoh NC; Farrell GC J Hepatol; 2014 Dec; 61(6):1376-84. PubMed ID: 25064435 [TBL] [Abstract][Full Text] [Related]
16. Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition. Nguyen G; Park SY; Le CT; Park WS; Choi DH; Cho EH Biochem Biophys Res Commun; 2018 Jan; 495(4):2649-2656. PubMed ID: 29278707 [TBL] [Abstract][Full Text] [Related]
17. Gliptins Suppress Inflammatory Macrophage Activation to Mitigate Inflammation, Fibrosis, Oxidative Stress, and Vascular Dysfunction in Models of Nonalcoholic Steatohepatitis and Liver Fibrosis. Wang X; Hausding M; Weng SY; Kim YO; Steven S; Klein T; Daiber A; Schuppan D Antioxid Redox Signal; 2018 Jan; 28(2):87-109. PubMed ID: 28635324 [TBL] [Abstract][Full Text] [Related]
18. IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner. Nishizawa H; Iguchi G; Fukuoka H; Takahashi M; Suda K; Bando H; Matsumoto R; Yoshida K; Odake Y; Ogawa W; Takahashi Y Sci Rep; 2016 Oct; 6():34605. PubMed ID: 27721459 [TBL] [Abstract][Full Text] [Related]
19. Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis. Cai CX; Buddha H; Castelino-Prabhu S; Zhang Z; Britton RS; Bacon BR; Neuschwander-Tetri BA Dig Dis Sci; 2017 Apr; 62(4):968-978. PubMed ID: 28194671 [TBL] [Abstract][Full Text] [Related]
20. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis. Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]